Biogened SA’s share price is zł19.9. Its GF Value is zł24.16. Based on the relationship between the current stock price and the GF Value, GuruFocus believes Biogened SA stock is .
The GF Value represents the current intrinsic value of a stock derived from our proprietary algorithm. It is based primarily on the historical multiples of where the stocks have been traded and the future growth of the business, adjusted for the past returns and growth. The GF Value has been verified by backtesting and daily updated model portfolios.
In addition to considering the current valuation, the growth potential of a company's value is equally important. Companies with faster growth rates tend to increase their value more quickly. Therefore, it's essential to look at the Price-to-Future GF Value ratios as well. The results are shown below:
| Price: zł19.9 | GF Value | Price/GF Value | ||
|---|---|---|---|---|
| Current | zł24.16 | 0.82 | ||
| Next FY1 End | zł25.21 | 0.79 | ||
| Next 12 Month | zł27.29 | 0.73 | ||
| Next FY2 End | zł28.34 | 0.70 |
GuruFocus performed a correlation analysis comparing Biogened SA's stock price with key financial metrics: revenue per share, book value per share, EPS without NRI, and operating cash flow per share.
The analysis reveals the strongest correlation between Biogened SA's stock price and Revenue per share, with a coefficient of 89%. This is followed by a 89% correlation with Earnings without NRI per share. Biogened SA’s stock price shows no significant correlation with Operating Cash Flow per share. Biogened SA’s stock price shows no significant correlation with Book Value per share.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
